DK126500B - Analogifremgangsmåde til fremstilling af 11-oxygenerede 9α,21-dihalogen-17α-alkanoyloxy-pregn-4-en-3,20-dioner. - Google Patents

Analogifremgangsmåde til fremstilling af 11-oxygenerede 9α,21-dihalogen-17α-alkanoyloxy-pregn-4-en-3,20-dioner.

Info

Publication number
DK126500B
DK126500B DK26769AA DK26769A DK126500B DK 126500 B DK126500 B DK 126500B DK 26769A A DK26769A A DK 26769AA DK 26769 A DK26769 A DK 26769A DK 126500 B DK126500 B DK 126500B
Authority
DK
Denmark
Prior art keywords
pregn
diones
dihalo
alkanoyloxy
oxygenated
Prior art date
Application number
DK26769AA
Other languages
Danish (da)
English (en)
Inventor
J Elks
G Phillipps
P May
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of DK126500B publication Critical patent/DK126500B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B7/00—Mountings, adjusting means, or light-tight connections, for optical elements
    • G02B7/20—Light-tight connections for movable optical elements
    • G02B7/22—Extensible connections, e.g. bellows

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Moulds For Moulding Plastics Or The Like (AREA)
DK26769AA 1968-01-19 1969-01-17 Analogifremgangsmåde til fremstilling af 11-oxygenerede 9α,21-dihalogen-17α-alkanoyloxy-pregn-4-en-3,20-dioner. DK126500B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3100/68A GB1253831A (en) 1968-01-19 1968-01-19 9alpha,21-DIHALOPREGNANE COMPOUNDS

Publications (1)

Publication Number Publication Date
DK126500B true DK126500B (da) 1973-07-23

Family

ID=9751941

Family Applications (1)

Application Number Title Priority Date Filing Date
DK26769AA DK126500B (da) 1968-01-19 1969-01-17 Analogifremgangsmåde til fremstilling af 11-oxygenerede 9α,21-dihalogen-17α-alkanoyloxy-pregn-4-en-3,20-dioner.

Country Status (14)

Country Link
US (1) US3721687A (US20100154137A1-20100624-C00004.png)
BE (1) BE727109A (US20100154137A1-20100624-C00004.png)
BR (1) BR6905681D0 (US20100154137A1-20100624-C00004.png)
CA (1) CA952900A (US20100154137A1-20100624-C00004.png)
CH (2) CH564035A5 (US20100154137A1-20100624-C00004.png)
DK (1) DK126500B (US20100154137A1-20100624-C00004.png)
ES (1) ES362679A1 (US20100154137A1-20100624-C00004.png)
FR (1) FR2000443A1 (US20100154137A1-20100624-C00004.png)
GB (1) GB1253831A (US20100154137A1-20100624-C00004.png)
IE (1) IE33204B1 (US20100154137A1-20100624-C00004.png)
IL (1) IL31447A (US20100154137A1-20100624-C00004.png)
NL (1) NL6900795A (US20100154137A1-20100624-C00004.png)
NO (1) NO132100C (US20100154137A1-20100624-C00004.png)
SE (1) SE350035B (US20100154137A1-20100624-C00004.png)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
US4154748A (en) * 1978-01-20 1979-05-15 The Upjohn Company Phosphate catalyzed acylation of steroidal tertiary alcohols
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4336200A (en) * 1980-01-31 1982-06-22 The Upjohn Company 17α-Acyloxy-5β-corticoids
EP0057401B1 (en) * 1981-02-02 1984-08-01 Schering Corporation Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
IT1194178B (it) * 1983-03-29 1988-09-14 Ricerche Steroidi Sirs Spa Soc Processo per la preparazione di 17-esteri di clobetasolo e composti ottenuti
ES2078175B1 (es) * 1993-12-31 1996-10-16 Cusi Lab Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
US20090304603A1 (en) * 2001-06-15 2009-12-10 Cuticeuticals, Inc. Topical steroid spray with botanic seed oils
US20040022741A1 (en) * 2001-06-15 2004-02-05 Crutchfield Charles E. Topical steroid spray
JP2007504123A (ja) * 2003-08-29 2007-03-01 ランバクシー ラボラトリーズ リミテッド Ｉｖ型ホスホジエステラーゼの阻害剤
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
US20110021473A1 (en) * 2006-09-22 2011-01-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
MX2009009793A (es) 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
US8796248B2 (en) 2007-10-05 2014-08-05 Nektar Therapeutics Oligomer-corticosteroid conjugates
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN101812107B (zh) * 2010-04-20 2013-05-01 浙江仙居仙乐药业有限公司 一种合成丙酸氯倍他索的方法
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same

Also Published As

Publication number Publication date
CH564563A5 (US20100154137A1-20100624-C00004.png) 1975-07-31
CA952900A (en) 1974-08-13
US3721687A (en) 1973-03-20
NO132100C (US20100154137A1-20100624-C00004.png) 1975-09-17
SE350035B (US20100154137A1-20100624-C00004.png) 1972-10-16
IE33204B1 (en) 1974-04-17
IL31447A (en) 1973-11-28
IE33204L (en) 1969-07-19
FR2000443A1 (US20100154137A1-20100624-C00004.png) 1969-09-05
NL6900795A (US20100154137A1-20100624-C00004.png) 1969-07-22
CH564035A5 (US20100154137A1-20100624-C00004.png) 1975-07-15
NO132100B (US20100154137A1-20100624-C00004.png) 1975-06-09
BE727109A (US20100154137A1-20100624-C00004.png) 1969-07-22
BR6905681D0 (pt) 1973-02-08
DE1902340B2 (de) 1977-06-08
GB1253831A (en) 1971-11-17
DE1902340A1 (de) 1969-09-11
ES362679A1 (es) 1971-02-01
IL31447A0 (en) 1969-03-27

Similar Documents

Publication Publication Date Title
DK126500B (da) Analogifremgangsmåde til fremstilling af 11-oxygenerede 9α,21-dihalogen-17α-alkanoyloxy-pregn-4-en-3,20-dioner.
DK111568B (da) Fremgangsmåde til fremstilling af N-alkyl-3,1-benzoxazin-2-oner.
DK140697B (da) Fremgangsmåde til fremstilling af 2-amino-4-hydroxy-6-hydroxymethyl-7,7-dimethyl-7,8-dihydropteridin.
DK125091B (da) Fremgangsmåde til fremstilling af 1-hydroxy-2-pyridoner.
DK125852B (da) Fremgangsmåde til fremstilling af erythromycylamin.
DK133430B (da) Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-aroylpyrrolidiner.
DK122124B (da) Fremgangsmåde til fremstilling af 2-acyloxythionobenzamider.
DK123236B (da) Fremgangsmåde til fremstilling af 2-alkyl-3-hydoxy-4,5-dihydrofuran-4-oner.
DK127971B (da) Analogifremgangsmåde til fremstilling af halogenmethyl-1,3-polyhalogen-2-propylethere.
DK123300B (da) Analogifremgangsmåde til fremstilling af thiophen-3-isonitriler.
DK123232B (da) Analogifremgangsmåde til fremstilling af 3-alkoxy-17α-propinylestra-1,3,5(10)-trien-17β-oler.
DK121052B (da) Fremgangsmåde til fremstilling af steroid-17α,21-orthocarbonater.
DK125464C (da) Analogifremgangsmåde til fremstilling af 6-halogen-15β, 16β-methylen-pregnanderivater.
DK128008B (da) Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner.
DK122454B (da) Fremgangsmåde til fremstilling af 9α,21,21-triklor-11β-fluor-pregn-4-en-3,20-dioner.
DK121759B (da) Analogifremgangsmåde til fremstilling af 3-oxo-7α-methylgona-4,9-diener.
DK120235B (da) Analogifremgangsmåde til fremstilling af 9α, 11β-disubstituerede 6α-fluor-16α-methyl-21-halogen-4-pregnen-3,20-dionderivater.
DK127107B (da) Fremgangsmåde til fremstilling af 17α-propadienyl-17β-hydroxy-steroider.
DK124882B (da) Analogifremgangsmåde til fremstilling af 17α-acyloxy-11β-methyl-19-norpregn-4-en-3,20-dioner.
DK123818B (da) Fremgangsmåde til fremstilling af 14β-hydroxy-card-20(22)-enolider eller -bufa-20,20-dienolider.
DK122816B (da) Analogifremgangsmåde til fremstilling af 3-aryl-5-methylhydantoiner.
DK140284B (da) Analogifremgangsmåde til fremstilling af oxazinobenzodiazepiner.
DK123936B (da) Analogifremgangsmåde til fremstilling af pregn-4-en-3-,20-dion-[17α,16α-d]-oxazoliner.
DK121440B (da) Analogifremgangsmåde til fremstilling af 2,4-bis-morpholino- eller-thiomorpholino-5-carbalkoxy-pyrimidiner.
DK128212B (da) Analogifremgangsmåde til fremstilling af thienylacetamider.

Legal Events

Date Code Title Description
PUP Patent expired